GNFT
GENFIT
Stock Euronext / Paris – Stock Market Prices, News & Analysis
Genfit is a biopharmaceutical company focused on developing therapeutic and diagnostic solutions for metabolic and liver diseases.
GENFIT
GNFT
Genfit is a biopharmaceutical company focused on developing therapeutic and diagnostic solutions for metabolic and liver diseases.
Price history of GENFIT
Price history of GENFIT
Performance & Momentum
Strategic Analysis
GENFIT • 2026
Genfit positions itself as a biopharmaceutical player specialized in the development of therapeutic and diagnostic solutions targeting metabolic and liver diseases, a segment with high unmet medical need. Its model combines innovative research and targeted clinical development, offering differentiation in a competitive European biotech sector.
- Strong expertise in metabolic and liver pathologies, a niche area with significant growth potential.
- Product portfolio integrating therapeutic and diagnostic approaches, enhancing synergy and added value.
- Solid track record of performance over several years, demonstrating the relevance of its development strategy.
- Dependence on clinical trial results, which entails a high inherent risk for valuation.
- Recent lack of major announcements, limiting visibility on the short-term evolution of projects.
Genfit's momentum is marked by very positive dynamics over the last semesters, supported by growing investor interest in high therapeutic potential biotechnologies. This trend reflects a relative confidence in the advancement of its programs, even in the absence of recent significant news.
Similar stocks to GENFIT
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
